Fatty acid synthase (FASN) inhibitor, Orlistat, Purity ≥98%

Synonym: 96829-58-2; Tetrahydrolipstatin; [(2S)-1-[(2S,3S)-3-Hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate; Fatty acid synthase (FASN) inhibitor

MDL: MFCD05662360
CAS Number: 96829-58-2
Compound CID: 3034010

Product Size

25 mg; 50 mg; 100 mg; 250 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Orlistat, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting fatty acid synthase (FASN). The molecular weight of the compound is 495.73, and its molecular formula is C₂₉H₅₃NO₅.

Molecular Weight

495.73

Molecular Formula

C₂₉H₅₃NO₅

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 97 mg/mL (195.67 mM); Water: insoluble; Ethanol: 97 mg/mL (195.67 mM); In vivo: 5% DMSO + 40% PEG 300 + 5% Tween 80 + ddH₂O, 12 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

Orlistat plays a key role in reducing fat absorption, leading to decreased calorie intake.